Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mersana Therapeutics Inc.

0.3250
-0.0257-7.33%
Volume:2.61M
Turnover:872.41K
Market Cap:40.51M
PE:-0.54
High:0.3581
Open:0.3569
Low:0.3233
Close:0.3507
Loading ...
Aug 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2021

Major Issues Report

8-K - Current report
Jun 17, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
Apr 09, 2021

Major Issues Report

8-K - Current report
Mar 11, 2021

Major Issues Report

8-K - Current report
Feb 26, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2021

Major Issues Report

8-K - Current report
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 12, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 05, 2021

Major Issues Report

8-K - Current report
Dec 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 30, 2020

Major Issues Report

8-K - Current report